Relationship Between Simulated Gadolinium-Based Contrast Agent Injection Profile and Achievable Resolution Metrics in Contrast-Enhanced Magnetic Resonance Angiography

被引:2
|
作者
Clark, Toshimasa J. [1 ]
Wilson, Gregory J. [2 ]
Maki, Jeffrey H. [1 ]
机构
[1] Univ Colorado, Dept Radiol, Abdominal Imaging Sect, Aurora, CO USA
[2] Bayer Healthcare, Bayer Radiol, Whippany, NJ USA
关键词
magnetic resonance angiography; contrast-enhanced magnetic resonance angiography; simulation; GADOBENATE DIMEGLUMINE; LIMITS;
D O I
10.1002/jmri.27966
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background Contrast bolus variation during contrast-enhanced magnetic resonance angiography (CE-MRA) acquisition may lead to vessel blurring. Purpose To combine knowledge of how contrast signal intensity (SI) evolves for different injection strategies with anatomically familiar parametric computer models to measure and visually assess the effects of a wide range of variables on modeled CE-MRA, and in doing so develop contrast rate injection guidelines. Study Type Computer modeling. Phantom Digital three-dimensional phantom consisting of orthogonal "aorta," 7 mm diameter "renal arteries" (with 57% and 86% diameter stenoses), and 7 mm diameter "superior mesenteric artery" (with 57% diameter stenosis). Field Strength/Sequence One millimeter in-plane resolution arterial CE-MRA imaging at 3 T. Assessment "Background" (time invariant) and "vascular" (time varying) components of the phantom were each Fourier transformed into the spatial frequency domain, the latter modulated by the SI evolution of a contrast bolus of varying "plateau" lengths and "tail" heights. Data are presented as surface plots of stenosis measurement error and blurring vs. a reference-standard injection. Statistical Tests Descriptive. Results Shorter plateau lengths and lower tail heights resulted in increased measured stenosis error and blurring vs. the reference standard. Under a 44-second acquisition, full width half maximum stenosis error of the 86% stenosis with 25% plateau length and 25% tail height is 24% as compared to that from the reference standard. As plateau length and tail height approach 100%, stenosis error and blurring approach a floor defined by the MR acquisition's limitations. Data Conclusion We propose that to achieve minimal degradation with CE-MRA, one can create a contrast bolus with either 60% plateau and 50% tail height or 80% plateau with any tail. These considerations may well prove to be of practical importance, possibly via manipulating the tail by means of multiphasic contrast injections. Level of Evidence 3 Technical Efficacy Stage 1
引用
收藏
页码:1797 / 1807
页数:11
相关论文
共 50 条
  • [41] Contrast-enhanced magnetic resonance angiography in congenital heart disease
    Marin Rodriguez, C.
    Maroto Alvaro, E.
    Sanchez Alegre, M. L.
    Ruiz Martin, Y.
    Delgado Carrasco, J.
    RADIOLOGIA, 2009, 51 (03): : 261 - 272
  • [42] Contrast-enhanced magnetic resonance angiography of the cervical arteries - A review
    Steffens, JC
    Link, J
    Heller, M
    INVESTIGATIVE RADIOLOGY, 1998, 33 (09) : 573 - 577
  • [43] Contrast-Enhanced Magnetic Resonance Angiography Following Subintimal Recanalization
    Abdel-Gawad, Ehab
    Harthun, Nancy
    Norton, Patrick
    Bonatti, Hugo
    Turba, Ulku
    Spinosa, David J.
    Bozlar, Ugur
    Ramkaransingh, Jeffrey R.
    Hagspiel, Klaus D.
    VASCULAR AND ENDOVASCULAR SURGERY, 2010, 44 (03) : 223 - 231
  • [44] Gadobenate dimeglumine (Multihance®) in Contrast-enhanced Magnetic Resonance Angiography
    La Ferla, R
    Daprà, M
    Hentrich, HR
    Pirovano, G
    Kirchin, MA
    ACADEMIC RADIOLOGY, 2002, 9 : S409 - S411
  • [45] Gadolinium-based magnetic resonance imaging contrast agents in interventional radiology
    Atar, E
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2004, 6 (07): : 412 - 414
  • [46] Relationship between gadolinium-based MRI contrast agent consumption and anthropogenic gadolinium in the influent of a wastewater treatment plant
    Laczovics, Attila
    Csige, Istvan
    Szabo, Sandor
    Toth, Albert
    Kalman, Ferenc Krisztian
    Toth, Imre
    Fulop, Zoltan
    Berenyi, Ervin
    Braun, Mihaly
    SCIENCE OF THE TOTAL ENVIRONMENT, 2023, 877
  • [47] Update on Gadolinium-Based Contrast Agent-Enhanced Imaging in the Genitourinary System
    Schieda, Nicola
    Krishna, Satheesh
    Davenport, Matthew S.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2019, 212 (06) : 1223 - 1233
  • [48] A glycosylated complex of gadolinium, a new potential contrast agent for magnetic resonance angiography?
    Yu, G.
    Yamashita, M.
    Aoshima, K.
    Takahashi, M.
    Oshikawa, T.
    Takayanagi, H.
    Laurent, S.
    Burtea, C.
    Vander Elst, L.
    Muller, R. N.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (08) : 2246 - 2249
  • [49] Use of gadolinium-based contrast agent for renal angiography: Case report and review of the literature
    Bassilios, N
    Vantelon, C
    Cluzel, P
    Baumelou, A
    Deray, G
    RENAL FAILURE, 2001, 23 (06) : 857 - 861
  • [50] Magnetic resonance imaging of endolymphatic hydrops: a comparison of methods with and without gadolinium-based contrast agent administration
    Ohashi, Toshio
    Naganawa, Shinji
    Nasu, Yusuke
    Kuno, Kayao
    Kato, Katsuhiko
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2023, 85 (02): : 299 - 309